ZyVersa Therapeutics (ZVSA) Short Interest Ratio & Short Volume $1.13 -0.01 (-0.88%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends ZyVersa Therapeutics Short Interest DataZyVersa Therapeutics (ZVSA) has a short interest of 45,500 shares, representing 4.25% of the float (the number of shares available for trading by the public). This marks a 369.07% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 3.57 million shares to cover all short positions.Current Short Interest45,500 sharesPrevious Short Interest9,700 sharesChange Vs. Previous Month+369.07%Dollar Volume Sold Short$91,455.00Short Interest Ratio0.0 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares2,340,000 sharesFloat Size1,070,000 sharesShort Percent of Float4.25%Today's Trading Volume141,409 sharesAverage Trading Volume3,573,949 sharesToday's Volume Vs. Average4% Short Selling ZyVersa Therapeutics? Sign up to receive the latest short interest report for ZyVersa Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartZVSA Short Interest Over TimeZVSA Days to Cover Over TimeZVSA Percentage of Float Shorted Over Time Ad Brownstone ResearchBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.Click here and I’ll tell you everything you need to know. ZyVersa Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202445,500 shares $91,455.00 +369.1%4.3%0 $2.01 10/15/20249,700 shares $22,310.00 -59.2%0.9%0.1 $2.30 9/30/202423,800 shares $57,120.00 +33.0%2.2%0.2 $2.40 9/15/202417,900 shares $39,022.00 -63.9%1.7%0.1 $2.18 8/31/202449,600 shares $136,896.00 +21.3%4.7%0.4 $2.76 8/15/202440,900 shares $123,518.00 -27.2%4.0%0.3 $3.02 Get the Latest News and Ratings for ZVSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/202456,200 shares $194,452.00 +68.3%6.8%0.4 $3.46 7/15/202433,400 shares $147,294.00 +76.7%4.0%0.1 $4.41 6/30/202418,900 shares $71,064.00 -46.0%2.3%0.1 $3.76 6/15/202435,000 shares $183,750.00 +797.4%4.2%0.2 $5.25 5/31/20243,900 shares $19,266.00 -73.8%0.5%0 $4.94 5/15/202414,900 shares $73,606.00 -4.5%1.8%0 $4.94 4/30/202415,600 shares $82,524.00 -96.6%2.1%0 $5.29 4/15/2024460,800 shares $292,838.40 -20.6%6.1%0.2 $0.64 3/31/2024580,600 shares $435,450.00 -10.1%8.1%0.2 $0.75 3/15/2024646,000 shares $504,203.00 -45.7%16.9%0.2 $0.78 2/29/20241,190,000 shares $1.31 million +619.5%74.4%0.4 $1.10 2/15/2024165,400 shares $95,402.72 -14.5%10.3%0.1 $0.58 1/31/2024193,500 shares $110,314.35 +545.0%1.5%0.2 $0.57 1/15/202430,000 shares $22,608.00 -51.6%0.2%0 $0.75 12/31/202362,000 shares $55,800.00 +38.1%0.5%0.1 $0.90 12/15/202344,900 shares $34,797.50 +152.3%0.4%0.1 $0.78 11/30/202317,800 shares $40,495.00 -99.2%0.1%0 $2.28 11/15/20232,300,000 shares $191,130.00 +25.7%18.3%0.3 $0.08 10/31/20231,830,000 shares $150,060.00 -26.8%14.6%0.3 $0.08 10/15/20232,500,000 shares $324,750.00 +86.6%19.9%0.5 $0.13 9/30/20231,340,000 shares $173,530.00 -63.1%10.7%0.3 $0.13 9/15/20233,630,000 shares $540,870.00 +1,168.8%28.9%0.8 $0.15 8/31/2023286,100 shares $40,683.42 -9.2%2.3%0.1 $0.14 8/15/2023315,100 shares $50,416.00 -52.4%2.5%0.2 $0.16 7/31/2023662,600 shares $114,298.50 -43.9%5.3%0.3 $0.17 7/15/20231,180,000 shares $293,466.00 +148.0%N/A0.4 $0.25 6/30/2023475,900 shares $116,833.45 -37.4%N/A0.2 $0.25 6/15/2023760,400 shares $250,932.00 +6.7%N/A0.4 $0.33 5/31/2023712,400 shares $260,738.40 +178.9%N/A0.4 $0.37 5/15/2023255,400 shares $110,409.42 No ChangeN/A0.2 $0.43 ZVSA Short Interest - Frequently Asked Questions What is ZyVersa Therapeutics' current short interest? Short interest is the volume of ZyVersa Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 45,500 shares of ZVSA short. 4.25% of ZyVersa Therapeutics' shares are currently sold short. Learn More on ZyVersa Therapeutics' current short interest. What is a good short interest percentage for ZyVersa Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.25% of ZyVersa Therapeutics' floating shares are currently sold short. Is ZyVersa Therapeutics' short interest increasing or decreasing? ZyVersa Therapeutics saw a increase in short interest in October. As of October 31st, there was short interest totaling 45,500 shares, an increase of 369.1% from the previous total of 9,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ZyVersa Therapeutics' float size? ZyVersa Therapeutics currently has issued a total of 2,340,000 shares. Some of ZyVersa Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ZyVersa Therapeutics currently has a public float of 1,070,000 shares. How does ZyVersa Therapeutics' short interest compare to its competitors? 4.25% of ZyVersa Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to ZyVersa Therapeutics: BioCardia, Inc. (3.17%), Creative Medical Technology Holdings, Inc. (1.38%), Guardion Health Sciences, Inc. (1.76%), CNS Pharmaceuticals, Inc. (1.98%), Biofrontera Inc. (12.12%), Pasithea Therapeutics Corp. (1.45%), Sonoma Pharmaceuticals, Inc. (4.14%), Tharimmune, Inc. (43.97%), Avenue Therapeutics, Inc. (3.74%), Aptorum Group Limited (0.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short ZyVersa Therapeutics stock? Short selling ZVSA is an investing strategy that aims to generate trading profit from ZyVersa Therapeutics as its price is falling. ZVSA shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ZyVersa Therapeutics? A short squeeze for ZyVersa Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ZVSA, which in turn drives the price of the stock up even further. How often is ZyVersa Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ZVSA, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies BioCardia Short Interest Creative Medical Technology Short Interest Guardion Health Sciences Short Interest CNS Pharmaceuticals Short Interest Biofrontera Short Interest Pasithea Therapeutics Short Interest Sonoma Pharmaceuticals Short Interest Tharimmune Short Interest Avenue Therapeutics Short Interest Aptorum Group Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ZVSA) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredReality Check: Are You Prepared for What's Next?Global shifts, like the alliance of BRICS nations pushing for economic independence from the U.S. dollar, and ...Allegiance Gold | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZyVersa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZyVersa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.